Loxo Oncology

10 Decision Makers Β· 14 Verified Contacts & Email Format

πŸ“ New York, NYPharmaceuticalsπŸ—“ Est. 2013πŸ‘₯ 501–1000 employees

About Loxo Oncology

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

Email Format

{first_letter_first_name}{last_name}@loxooncology.com β€” 87.5%

ssmith@loxooncology.com

{first_name}@loxooncology.com β€” 12.5%

sarah@loxooncology.com

Leadership & Decision Makers

Contact details of 10 Loxo Oncology decision makers

Lee S Scheible

Director, Early Phase Oncology, Loxo Oncology at Lilly LinkedIn
  • Work email

    l*******e@loxooncology.com

Jinmi Heo

Director LinkedIn
  • Work email

    j**o@loxooncology.com

Tamas Benkovics

Director LinkedIn
  • Work email

    t********s@loxooncology.com

Alba Luengo

Principal Scientist LinkedIn
  • Work email

    a*****o@loxooncology.com

Nisha Nanda

Director, Clinical Science and Development
  • Work email

    n***a@loxooncology.com

Steven Andrews

Senior Vice President, Small Molecule Discovery

Josh Bilenker

Founder, President & CEO

Shelley Force Aldred

Consulting Senior Director

Susanne Rhoades

Senior Director, Diagnostic Development

Jacob Van Naarden

Chief Operating Officer

Team & Specialists

Contact details of 4 Loxo Oncology team members

Bojana Jovanovic

Senior Scientific Lead, Clinical Biomarker Development LinkedIn
  • Work email

    b********c@loxooncology.com

Tracey Marrone

Talent Acquisition Manager LinkedIn
  • Work email

    t******e@loxooncology.com

Nathan Wright

Research Fellow LinkedIn
  • Work email

    n*****t@loxooncology.com

Ipsita Roy

Sr. Program/Project Manager
  • Work email

    i**y@loxooncology.com

General Emails

General company emails, e.g. customer support lines

    info@loxooncology.com

    General Inquiries

    clinicaltrials@loxooncology.com

    Unclassified inbox

    careers@loxooncology.com

    Unclassified inbox

    jake@loxooncology.com

    Unclassified inbox

    bschmitz@loxooncology.com

    Unclassified inbox

    cbethune@loxooncology.com

    Unclassified inbox

Similar Companies like Loxo Oncology

Seagen

seagen.com
Biotechnology Β· Bothell, Washington, United States Β· Est. 1998 Β· 1001–5000 employees Β· $500M–$1B

HQ: Bothell, Washington, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology Β· Temple City, California, United States Β· Est. 2011 Β· 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals Β· Northbrook, Illinois, United States Β· Est. 2005 Β· 1001–5000 employees

HQ: Northbrook, Illinois, United States

Biotechnology Β· New York, NY Β· Est. 1849 Β· Above 10001 employees

HQ: New York, NY

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 27/07/2025

+1 203-653-3880

New York, NY

Specialization: Biopharmaceutical, Genetics, Oncology, Therapeutics
Legal Name: Loxo Oncology, Inc.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +1 203-653-3880
Last Investment Activity: Oct 17, 2022
Investments Activity: Oct 17, 2022 Jul 30, 2021 Jul 29, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.